Figure 2From: Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panelsBiomarker assay integration utilizing high performance nano-separation (RT: retention time, AA: peak area, using automatic integration).Back to article page
